ClinicalTrials.Veeva

Menu

Trial of Direct Home Delivery of Colorectal Cancer Screening Kit Without Pre-ordering (EXPEDIT)

C

Caen University Hospital

Status

Enrolling

Conditions

Colorectal Cancer

Treatments

Other: CRC screening invitation not including the screening test.
Other: Mailing of FIT with invitation
Other: Information letter before invitation

Study type

Interventional

Funder types

Other

Identifiers

NCT06032338
2022-A01914-39

Details and patient eligibility

About

The effect of mailing FIT with the invitation on participation and colonoscopy rates will be evaluated in a randomized controlled trial conducted in the Centre-Val de Loire (CVL) region, involving 64,000 people from the population eligible for colorectal cancer population-based organised screening program (CRC-PBOSP).

In the "C" control group, invitations, test delivery and reminders will be carried out in accordance with the CRC-PBOSP rules at the time of the study.

Intervention group "B" will evaluate two experimental modes of invitation with direct home mailing of the test:

  • Method "B1": invitation with test sent to home without prior information letter
  • Method "B2": information letter followed by invitation with test sent home, designed to optimize participation by first-time subjects (aged 50-51) invited to the CRC-PBOSP for the first time.

Ancillary studies will focus 1/ on acceptability of this intervention (qualitative study on a few general practitioners, gastroenterologists and invitees), 2/ on social and geographical inequalities of participation on a subsample of individuals included in EXPEDIT study using ecological indices (EDI, SCALE).

Enrollment

64,000 estimated patients

Sex

All

Ages

50 to 74 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 50 to 74 years old
  • Resident of Centre Val de Loire French area
  • Eligible for CRC screening invitation within the biennal CRC-PBOSP during the inclusion period
  • Affiliated to the health insurance scheme

Exclusion criteria

  • CRC screening exclusion criteria notified to CRCDC-CVL in a previous screening round (family or personal history of CRC/adenoma, inflammatory bowel disease)
  • Colonoscopy in the previous 5 years)

Subjects refusing data transmission to research team will be excluded from statistical analyses.

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

64,000 participants in 3 patient groups

Control "C"
Other group
Description:
Usual care : Screening test (Fecal immunochemical test - FIT) delivery and reminders will be carried out in accordance with the Colorectal cancer population-based organised screening program (CRC-PBOSP) specifications at the time of the study. This arm is suitable for both the first screening round in 50-51 years old population, and for the subsequent screening rounds.
Treatment:
Other: CRC screening invitation not including the screening test.
Intervention "B1"
Experimental group
Description:
FIT mailed at home within the CRC screening invitation without prior information letter. This arm is suitable for both the first screening round in 50-51 years old population, and for the subsequent screening rounds.
Treatment:
Other: Mailing of FIT with invitation
Intervention "B2"
Experimental group
Description:
FIT mailed at home within the CRC screening invitation with prior information letter. This arm is suitable for the first screening round in 50-51 years old population only.
Treatment:
Other: Mailing of FIT with invitation
Other: Information letter before invitation

Trial contacts and locations

1

Loading...

Central trial contact

Lydia GUITTET, MD,PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems